NOS3 and cardiovascular disorder: Indeed, by inhibiting endothelial NOS, ADMA might increase the risk of vascular inflammation and thrombosis, such that elevated plasma ADMA has been reported to be a risk factor for cardiovascular morbidity and mortality in patients with cardiovascular disease [33].